BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 20396707)

  • 1. Age-specific morphofunctional changes in cambial cells and their derivatives in human skin.
    Yavisheva TM; Shcherbakov SD
    Bull Exp Biol Med; 2009 Sep; 148(3):437-40. PubMed ID: 20396707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peculiarities of proliferation and differentiation of cambial and daughter cells of epidermal-dermal morphofunctional zone in normal epithelium and in cancer.
    Yavisheva TM; Shcherbakov SD
    Bull Exp Biol Med; 2010 Oct; 149(4):521-6. PubMed ID: 21234456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of proliferation and differentiation of cambial and daughter cells in morphofunctional zones in the normal epithelium and cancer using age aspect].
    Iavisheva TM; Shcherbakov SD
    Adv Gerontol; 2009; 22(4):605-13. PubMed ID: 20405727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Melanoma and cancer emergence in persons of 20-60 years against normal quantity of cambial cells in morphofunctional zones].
    Iavisheva TM; Shchebakov SD
    Adv Gerontol; 2014; 27(4):753-7. PubMed ID: 25946855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of cambial dermal cells (fibroblasts) and epidermis in morphofunctional area of mouse skin.
    Yavisheva TM; Shcherbakov SD; Golubeva IS; Sharafutdinov GZ
    Bull Exp Biol Med; 2007 Nov; 144(5):748-53. PubMed ID: 18683514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Participation of morphofunctional zones in aging processes].
    Iavisheva TM; Shcherbakov SD
    Adv Gerontol; 2012; 25(4):604-11. PubMed ID: 23734504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural organization of the basal layer and morphofunctional characteristics of mouse epidermal cambial cells.
    Yavisheva TM; Shcherbakov SD; Golubeva IS; Sharafutdinov GZ; Savluchinskaya LA
    Bull Exp Biol Med; 2004 May; 137(5):513-6. PubMed ID: 15455132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the common mechanisms of cambial somatic and sex cells proliferation and the notion of the cambial cells.
    Yavisheva TM; Shcherbakov SD
    Bull Exp Biol Med; 2012 May; 153(1):82-5. PubMed ID: 22808500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of epidermal melanocytes and langerhans cells with epidermal cambial cells.
    Yavisheva TM; Shcherbakov SD; Golubeva IS; Savluchinskaya LA; Ryzhova NI
    Bull Exp Biol Med; 2012 Jul; 153(3):367-70. PubMed ID: 22866314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The SH4-Unique-SH3-SH2 domains dictate specificity in signaling that differentiate c-Yes from c-Src.
    Summy JM; Qian Y; Jiang BH; Guappone-Koay A; Gatesman A; Shi X; Flynn DC
    J Cell Sci; 2003 Jun; 116(Pt 12):2585-98. PubMed ID: 12734402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin-like growth factor 1 receptor is expressed by epithelial cells with proliferative potential in human epidermis and skin appendages: correlation of increased expression with epidermal hyperplasia.
    Hodak E; Gottlieb AB; Anzilotti M; Krueger JG
    J Invest Dermatol; 1996 Mar; 106(3):564-70. PubMed ID: 8648195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of Src-like adaptor protein 2 reveals close association of SH3 and SH2 domains through β-sheet formation.
    Wybenga-Groot LE; McGlade CJ
    Cell Signal; 2013 Dec; 25(12):2702-8. PubMed ID: 24018043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of the work of morphofunctional zones in normal epithelium, fibroadenoma, and cancer of the breast.
    Yavisheva TM; Shcherbakov SD; Golubeva IS; Savluchinskaya LA
    Bull Exp Biol Med; 2005 Aug; 140(2):231-4. PubMed ID: 16283009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the Src homology domains in morphological transformation by v-src.
    Tian M; Martin GS
    Mol Biol Cell; 1997 Jul; 8(7):1183-93. PubMed ID: 9243500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA; Cheng HY; Smithgall TE
    Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
    Tian M; Martin GS
    Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mammalian adaptor protein with conserved Src homology 2 and phosphotyrosine-binding domains is related to Shc and is specifically expressed in the brain.
    O'Bryan JP; Songyang Z; Cantley L; Der CJ; Pawson T
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2729-34. PubMed ID: 8610109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and cocrystal structure of a nonpeptide Src SH2 domain ligand.
    Plummer MS; Holland DR; Shahripour A; Lunney EA; Fergus JH; Marks JS; McConnell P; Mueller WT; Sawyer TK
    J Med Chem; 1997 Nov; 40(23):3719-25. PubMed ID: 9371236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.
    Nam NH; Pitts RL; Sun G; Sardari S; Tiemo A; Xie M; Yan B; Parang K
    Bioorg Med Chem; 2004 Feb; 12(4):779-87. PubMed ID: 14759738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites.
    Lombardo CR; Consler TG; Kassel DB
    Biochemistry; 1995 Dec; 34(50):16456-66. PubMed ID: 8845374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.